Attendees:
Qing Zeng-Treitler, Allen Browne, Guy Divita, Alla Keselman, Catherine Arnott-Smith, Gondy Leroy, Sergey Goryachev, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. The team is working on the final revisions for the two manuscripts (please see the prior meetings)
2. The team reviewed 20 terms retrieved from the clinical trials corpus. They found many ambiguous abbreviations and difficult technical terms that do not have lay equivalents. Term review will continue.
Qing Zeng-Treitler, Allen Browne, Guy Divita, Alla Keselman, Catherine Arnott-Smith, Gondy Leroy, Sergey Goryachev, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. The team is working on the final revisions for the two manuscripts (please see the prior meetings)
2. The team reviewed 20 terms retrieved from the clinical trials corpus. They found many ambiguous abbreviations and difficult technical terms that do not have lay equivalents. Term review will continue.
Attendees:
Qing Zeng-Treitler, Alla Keselman, Guy Divita, Allen Browne, Rosa Figueroa, Sergey Goryachev, Hyeoneui Kim
Discussions:
1. the team discussed several issues raised by the reviewers regarding the manuscript on the unmapped concept study.
2. the team briefly discussed the comparative evaluation process of the taggers developed by NLM and DSG-MIT.
Qing Zeng-Treitler, Alla Keselman, Guy Divita, Allen Browne, Rosa Figueroa, Sergey Goryachev, Hyeoneui Kim
Discussions:
1. the team discussed several issues raised by the reviewers regarding the manuscript on the unmapped concept study.
2. the team briefly discussed the comparative evaluation process of the taggers developed by NLM and DSG-MIT.
Attendees:
Qing Zeng-Treitler, Allen Browne, Alla Keselman, Guy Divita, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. The authors will restructure the white paper to make it more cohesive and better reads.
2. the team reviewed 21 terms retrieved from clinical trials protocols to add them to the CHV.
Qing Zeng-Treitler, Allen Browne, Alla Keselman, Guy Divita, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. The authors will restructure the white paper to make it more cohesive and better reads.
2. the team reviewed 21 terms retrieved from clinical trials protocols to add them to the CHV.
Attendees:
Qing Zeng-Treitler, Alla Keselman, Robert Logan, Gondy Leroy, Catherine Arnott-Smith, Allen Browne, Guy Divita, Sergey Goryachev, Sasi Kandula, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. White paper on "Consumer centered health communication" - formatting & editorial revision plans were discussed
2. The team will start revising the manuscript on the unmapped concept study next week
Qing Zeng-Treitler, Alla Keselman, Robert Logan, Gondy Leroy, Catherine Arnott-Smith, Allen Browne, Guy Divita, Sergey Goryachev, Sasi Kandula, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. White paper on "Consumer centered health communication" - formatting & editorial revision plans were discussed
2. The team will start revising the manuscript on the unmapped concept study next week
Attendees:
Qing Zeng_Treitler, Allen Browne, Alla Keselman, Guy Divita, Catherine Arnott-Smith, Rosa Figueroa, Sergey Goryachev, Sasi Kandula, Hyeoneui Kim
Discussions:
1. obscene terms and abbreviations used by consumers require careful review. the team will refer to several sources and determine their legitimacy as a term.
2. the team also discussed revising the white paper
Qing Zeng_Treitler, Allen Browne, Alla Keselman, Guy Divita, Catherine Arnott-Smith, Rosa Figueroa, Sergey Goryachev, Sasi Kandula, Hyeoneui Kim
Discussions:
1. obscene terms and abbreviations used by consumers require careful review. the team will refer to several sources and determine their legitimacy as a term.
2. the team also discussed revising the white paper
Attendees:
Qing Zeng-Treitler, Allen Browne, Guy Divita, Gondy Leroy, Alla Keselman, Catherine Arnott-Smith, Sergey Goryachev, Sasi Kandula, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. The team discussed on the white paper preparation
2. There will be 5 paper and panel presentations and 2 poster presentation by the team members at the AMIA 07
3. Qing Zeng has been elected as a new chairman of the consumer health informatics working group of the AMIA. Congratulations!
Qing Zeng-Treitler, Allen Browne, Guy Divita, Gondy Leroy, Alla Keselman, Catherine Arnott-Smith, Sergey Goryachev, Sasi Kandula, Rosa Figueroa, Hyeoneui Kim
Discussions:
1. The team discussed on the white paper preparation
2. There will be 5 paper and panel presentations and 2 poster presentation by the team members at the AMIA 07
3. Qing Zeng has been elected as a new chairman of the consumer health informatics working group of the AMIA. Congratulations!
Attendees:
Qing Zeng-Treitler, Allen Browne, Guy Divita, Catherine Arnott-Smith, Sasi Kandula, Rosa Figueroa, Hyeoneui Kim
Discussions:
The team reviewed additional 20 most frequently appeared terms from the clinical trials corpus and identified their consumer friendlier expressions.
Qing Zeng-Treitler, Allen Browne, Guy Divita, Catherine Arnott-Smith, Sasi Kandula, Rosa Figueroa, Hyeoneui Kim
Discussions:
The team reviewed additional 20 most frequently appeared terms from the clinical trials corpus and identified their consumer friendlier expressions.
Attendees:
Alla Keselman, Qing Zeng-Treitler, Allen Browne, Gondy Leroy, Sasi Kandula, Sergey Goryachev, Rosa Figueroa, Hyeoneui Kim
Discussions:
The team continued reviewing the term list obtained from the clinical trials corpus.
Top 30 most frequently appeared in the corpus were closely reviewed and their consumer friendlier expressions were determined.
Alla Keselman, Qing Zeng-Treitler, Allen Browne, Gondy Leroy, Sasi Kandula, Sergey Goryachev, Rosa Figueroa, Hyeoneui Kim
Discussions:
The team continued reviewing the term list obtained from the clinical trials corpus.
Top 30 most frequently appeared in the corpus were closely reviewed and their consumer friendlier expressions were determined.
Attendees:
Qing Zeng-Treitler, Alla Keselman, Allen Browne, Catherine Arnott Smith, Sasi Kandula, Sergeu Goryachev, Rosa Figueroa, Hyeoneui Kim
Discussions:
The team reviewed the term frequencies obtained from the Clinical Trials corpus. They observed that a number of common terms were not included in the UMLS as well as in the CHV.
Qing Zeng-Treitler, Alla Keselman, Allen Browne, Catherine Arnott Smith, Sasi Kandula, Sergeu Goryachev, Rosa Figueroa, Hyeoneui Kim
Discussions:
The team reviewed the term frequencies obtained from the Clinical Trials corpus. They observed that a number of common terms were not included in the UMLS as well as in the CHV.
Attendees:
Qing Zeng-Treitler, Alla Keselman, Allen Browne, Guy Divita, Catherine Arnott-Smith, Sergey Goryachev, Hyeoneui Kim
Discussions:
1. Sample CHV tables - the team agreed to create a table that links the string level, concept level, and term level IDs (like MRCON table of the UMLS).
2. white paper preparation is progressing well. the team will start sharing feedback on the draft manuscript.
3. the team will have an off-line meeting at AMIA in Chicago (Time and place TBD).
Qing Zeng-Treitler, Alla Keselman, Allen Browne, Guy Divita, Catherine Arnott-Smith, Sergey Goryachev, Hyeoneui Kim
Discussions:
1. Sample CHV tables - the team agreed to create a table that links the string level, concept level, and term level IDs (like MRCON table of the UMLS).
2. white paper preparation is progressing well. the team will start sharing feedback on the draft manuscript.
3. the team will have an off-line meeting at AMIA in Chicago (Time and place TBD).
